None
Quote | Rexahn Pharmaceuticals (NYSE:REXN)
Last: | $ |
---|---|
Change Percent: | -9.02% |
Open: | $3.12 |
Close: | $3.33 |
High: | $3.60 |
Low: | $2.99 |
Volume: | 3,197,318 |
Last Trade Date Time: | 02/12/2020 04:42:01 pm |
News | Rexahn Pharmaceuticals (NYSE:REXN)
FARMINGTON HILLS, Mich., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, today announced that will participate in the H.C. Wainwrigh...
Merger completed with Rexahn Pharmace u ticals c reat ing a Nasdaq-listed Biopharmaceutical Company Focused on Advancing Ocuphire’s Late-Stage Clinical Pipeline of Ophthalmic Drug Candidates Trading under "OCUP" on the Nasdaq Capital Market to begin No...
Message Board Posts | Rexahn Pharmaceuticals (NYSE:REXN)
Subject | By | Source | When |
---|---|---|---|
11/06/2020: $REXN now re-brands with new ticker | saturn_five | investorshub | 11/06/2020 1:26:45 AM |
Following closing, which is expected to occur in | kpisme | investorshub | 08/28/2020 6:18:54 PM |
Does anybody know when the merger is suppose | geenback | investorshub | 08/27/2020 4:44:07 PM |
* * $REXN Video Chart 02-12-2020 * * | ClayTrader | investorshub | 02/12/2020 11:18:34 PM |
Total shares traded today 19.6 mill Thats almost 5x | ttubular | investorshub | 02/11/2020 11:14:28 PM |
News, Short Squeeze, Breakout and More Instantly...
Rexahn Pharmaceuticals Company Name:
REXN Stock Symbol:
NYSE Market:
FARMINGTON HILLS, Mich., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, today announced that will participate in the H.C. Wainwrigh...
Merger completed with Rexahn Pharmace u ticals c reat ing a Nasdaq-listed Biopharmaceutical Company Focused on Advancing Ocuphire’s Late-Stage Clinical Pipeline of Ophthalmic Drug Candidates Trading under "OCUP" on the Nasdaq Capital Market to begin No...
ROCKVILLE, Md., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN) (“Rexahn”) announced today that the merger transaction between Rexahn and Ocuphire Pharma, Inc. is expected to be effective shortly after 4:00 pm (EST) today, Thursday, November 5, 202...